25 related articles for article (PubMed ID: 15501953)
1. The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review.
Binder MJ; Ward AC
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808504
[TBL] [Abstract][Full Text] [Related]
2. A Hierarchical Machine Learning Model to Discover Gleason Grade-Specific Biomarkers in Prostate Cancer.
Hamzeh O; Alkhateeb A; Zheng JZ; Kandalam S; Leung C; Atikukke G; Cavallo-Medved D; Palanisamy N; Rueda L
Diagnostics (Basel); 2019 Dec; 9(4):. PubMed ID: 31835700
[TBL] [Abstract][Full Text] [Related]
3. Wnt signaling in castration-resistant prostate cancer: implications for therapy.
Yokoyama NN; Shao S; Hoang BH; Mercola D; Zi X
Am J Clin Exp Urol; 2014 Apr; 2(1):27-44. PubMed ID: 25143959
[TBL] [Abstract][Full Text] [Related]
4. Primary cilia are lost in preinvasive and invasive prostate cancer.
Hassounah NB; Nagle R; Saboda K; Roe DJ; Dalkin BL; McDermott KM
PLoS One; 2013; 8(7):e68521. PubMed ID: 23844214
[TBL] [Abstract][Full Text] [Related]
5. Interaction between the TP63 and SHH pathways is an important determinant of epidermal homeostasis.
Chari NS; Romano RA; Koster MI; Jaks V; Roop D; Flores ER; Teglund S; Sinha S; Gruber W; Aberger F; Medeiros LJ; Toftgard R; McDonnell TJ
Cell Death Differ; 2013 Aug; 20(8):1080-8. PubMed ID: 23686138
[TBL] [Abstract][Full Text] [Related]
6. LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer.
Romanuik TL; Wang G; Morozova O; Delaney A; Marra MA; Sadar MD
BMC Med Genomics; 2010 Sep; 3():43. PubMed ID: 20868494
[TBL] [Abstract][Full Text] [Related]
7. N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells.
Dagvadorj A; Tan SH; Liao Z; Xie J; Nurmi M; Alanen K; Rui H; Mirtti T; Nevalainen MT
Int J Biochem Cell Biol; 2010 Dec; 42(12):2037-46. PubMed ID: 20854925
[TBL] [Abstract][Full Text] [Related]
8. Redefining hormone resistance in prostate cancer.
Hoimes CJ; Kelly WK
Ther Adv Med Oncol; 2010 Mar; 2(2):107-123. PubMed ID: 20543967
[TBL] [Abstract][Full Text] [Related]
9. Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer.
McDonnell TJ; Chari NS; Cho-Vega JH; Troncoso P; Wang X; Bueso-Ramos CE; Coombes K; Brisbay S; Lopez R; Prendergast G; Logothetis C; Do KA
BMC Med Genomics; 2008 Jan; 1():1. PubMed ID: 18237448
[TBL] [Abstract][Full Text] [Related]
10. MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor.
Genitsch V; Zlobec I; Thalmann GN; Fleischmann A
Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):242-7. PubMed ID: 27165976
[TBL] [Abstract][Full Text] [Related]
11. Involvement of growth factor receptors of the epidermal growth factor receptor family in prostate cancer development and progression to androgen independence.
Lorenzo GD; Bianco R; Tortora G; Ciardiello F
Clin Prostate Cancer; 2003 Jun; 2(1):50-7. PubMed ID: 15046685
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biomarker correlates of androgen-independent, locally aggressive prostate cancer with limited metastatic potential.
Assikis VJ; Do KA; Wen S; Wang X; Cho-Vega JH; Brisbay S; Lopez R; Logothetis CJ; Troncoso P; Papandreou CN; McDonnell TJ
Clin Cancer Res; 2004 Oct; 10(20):6770-8. PubMed ID: 15501953
[TBL] [Abstract][Full Text] [Related]
13. RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.
Prensner JR; Zhao S; Erho N; Schipper M; Iyer MK; Dhanasekaran SM; Magi-Galluzzi C; Mehra R; Sahu A; Siddiqui J; Davicioni E; Den RB; Dicker AP; Karnes RJ; Wei JT; Klein EA; Jenkins RB; Chinnaiyan AM; Feng FY
Lancet Oncol; 2014 Dec; 15(13):1469-1480. PubMed ID: 25456366
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum progastrin-releasing peptide (31-98) in metastatic and androgen-independent prostate cancer patients.
Yashi M; Muraishi O; Kobayashi Y; Tokue A; Nanjo H
Prostate; 2002 May; 51(2):84-97. PubMed ID: 11948963
[TBL] [Abstract][Full Text] [Related]
15. Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment.
Tzelepi V; Efstathiou E; Wen S; Troncoso P; Karlou M; Pettaway CA; Pisters LL; Hoang A; Logothetis CJ; Pagliaro LC
J Clin Oncol; 2011 Jun; 29(18):2574-81. PubMed ID: 21606419
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
